SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-17-001198
Filing Date
2017-03-01
Accepted
2017-03-01 09:31:17
Documents
68
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K glyc-20161231x10k.htm 10-K 2456822
2 EX-23.1 glyc-20161231ex231e0da66.htm EX-23.1 8293
3 EX-31.1 glyc-20161231ex31160ffc0.htm EX-31.1 13063
4 EX-31.2 glyc-20161231ex31258d33f.htm EX-31.2 13236
5 EX-32.1 glyc-20161231ex3211bfe4e.htm EX-32.1 11171
6 GRAPHIC glyc20161231x10k001.jpg GRAPHIC 284796
7 GRAPHIC glyc20161231x10k002.jpg GRAPHIC 76194
8 GRAPHIC glyc20161231x10k003.jpg GRAPHIC 65088
  Complete submission text file 0001558370-17-001198.txt   7809408

Data Files

Seq Description Document Type Size
9 EX-101.INS glyc-20161231.xml EX-101.INS 1390651
10 EX-101.SCH glyc-20161231.xsd EX-101.SCH 38731
11 EX-101.CAL glyc-20161231_cal.xml EX-101.CAL 40942
12 EX-101.DEF glyc-20161231_def.xml EX-101.DEF 186457
13 EX-101.LAB glyc-20161231_lab.xml EX-101.LAB 366587
14 EX-101.PRE glyc-20161231_pre.xml EX-101.PRE 315220
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36177 | Film No.: 17651699
SIC: 2834 Pharmaceutical Preparations